STRATEGIES FOR THE CLINICAL DEVELOPMENT OF ANTI-CYTOKINES

被引：0
|
作者：
FENNER, H
机构：
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 1993年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S183 / S184
页数：2
相关论文
共 50 条
  • [21] VALUING CLINICAL STRATEGIES EARLY IN THEIR DEVELOPMENT
    WELCH, HG
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (03) : 263 - 264
  • [22] Career Development Strategies for the Clinical Educator
    Mandel, Jess
    ATS SCHOLAR, 2020, 1 (02): : 101 - 109
  • [23] Teaching strategies for the development of clinical reasoning
    Neistadt, ME
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 1996, 50 (08): : 676 - 684
  • [24] ANTI-AIDS DRUG DEVELOPMENT - CHALLENGES AND STRATEGIES
    MOHAN, P
    PHARMACEUTICAL RESEARCH, 1992, 9 (06) : 703 - 714
  • [25] NEW STRATEGIES IN THE DEVELOPMENT OF ANTI-ATHEROSCLEROTIC DRUGS
    SIRTORI, CR
    TREMOLI, E
    PAOLETTI, R
    ARTERY, 1980, 8 (06) : 507 - 518
  • [26] Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors
    Shaohua Liao
    Chuanfen Li
    Xiaoying Bi
    Hongwei Guo
    Ying Qian
    Xiaobei Liu
    Shuai Miao
    Huaiqiang Hu
    Bingzhen Cao
    Journal of Neuroinflammation, 18
  • [27] Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors
    Liao, Shaohua
    Li, Chuanfen
    Bi, Xiaoying
    Guo, Hongwei
    Qian, Ying
    Liu, Xiaobei
    Miao, Shuai
    Hu, Huaiqiang
    Cao, Bingzhen
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [28] COURSE STRATEGIES FOR CLINICAL NURSE LEADER DEVELOPMENT
    Gerard, Sally
    Grossman, Sheila
    Godfrey, Marjorie
    JOURNAL OF PROFESSIONAL NURSING, 2012, 28 (03) : 147 - 155
  • [29] Faculty Development and Other Strategies for Clinical Teaching
    Clare, Camille A.
    Yeh, John
    CURRENT WOMENS HEALTH REVIEWS, 2015, 11 (02) : 131 - 136
  • [30] Anti-VEGF Strategies - from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
    Korpanty, Grzegorz
    Smyth, Elizabeth
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (19) : 2680 - 2701
12345